NCT00260793View on ClinicalTrials.gov

Open Label High Dose Ropinirole (Requip) Study for Patients With Parkinson's Disease

PHASE3UnknownINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

November 30, 2005

Conditions

Parkinson's Disease

Interventions

DRUG

Ropinirole Hydrochloride

Trial Locations (1)

80113

RECRUITING

Colorado Neurology, P.C., Englewood

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

Colorado Neurology

OTHER

collaborator

GlaxoSmithKline

INDUSTRY

lead

Agarwal, Pinky, M.D.

INDIV